topicTocotrienol Cholesterol Meta-Analysis
claimNutritional demands increase during this period, but populations with limited access to vitamin E–rich foods, such as oils, nuts, and seeds, are at risk of deficiency (Rebouças et al. ; Busso et al. ).
evidence level1
citationCarneiro Byanca Rodrigues (2026)
sourceEfficacy of Vitamin E Supplementation During Pregnancy on the Vitamin E Nutritional Status of the Mother–Child Dyad: A Systematic Review and Meta‐Analysis of Randomized Controlled Trial
topicTocotrienol Cholesterol Meta-Analysis
claim2015 2005 2005 2014 2021 2015 Recent studies suggest that low vitamin E levels, defined as serum concentrations below 12 μmol/L (Péter et al. ), increase maternal oxidative stress, thereby raising the risk of complications such as preeclampsia and placental abruption (Debier and Larondelle ).
evidence level1
citationCarneiro Byanca Rodrigues (2026)
sourceEfficacy of Vitamin E Supplementation During Pregnancy on the Vitamin E Nutritional Status of the Mother–Child Dyad: A Systematic Review and Meta‐Analysis of Randomized Controlled Trial
topicTocotrienol Cholesterol Meta-Analysis
claimfound that vitamin E combined with other supplements did not prevent fetal or neonatal death, preterm birth, preeclampsia, or IUGR, but the lack of data on isolated α‐TOH prevents conclusions about its independent effect (Rumbold et al. ).
evidence level1
citationCarneiro Byanca Rodrigues (2026)
sourceEfficacy of Vitamin E Supplementation During Pregnancy on the Vitamin E Nutritional Status of the Mother–Child Dyad: A Systematic Review and Meta‐Analysis of Randomized Controlled Trial
topicTocotrienol Cholesterol Meta-Analysis
claim2017 2018 2021 Vitamin E is a group of fat‐soluble compounds that includes tocopherols and tocotrienols, each subdivided into four distinct forms (α‐, β‐, γ‐, and δ‐).
evidence level1
citationCarneiro Byanca Rodrigues (2026)
sourceEfficacy of Vitamin E Supplementation During Pregnancy on the Vitamin E Nutritional Status of the Mother–Child Dyad: A Systematic Review and Meta‐Analysis of Randomized Controlled Trial
topicTocotrienol Cholesterol Meta-Analysis
claimHyperlipidemia, characterized by elevated lipid levels, is a major risk factor for cardiovascular diseases (CVD), including atherosclerosis.
evidence level1
citationAbdah HW (2025)
sourceEffect of tocotrienol-rich fraction (TRF) on lipid profile in hyperlipidemic experimental animal model: a systematic review and meta-analysis.
topicTocotrienol Cholesterol Meta-Analysis
claimTRF significantly reduced total cholesterol (effect size = - 4.675, p < 0.0001), LDL (- 4.847, p < 0.0001), and triglycerides (- 4.736, p < 0.0001), while significantly increasing HDL (4.001, p < 0.0001), particularly in rats and mice.
evidence level1
citationAbdah HW (2025)
sourceEffect of tocotrienol-rich fraction (TRF) on lipid profile in hyperlipidemic experimental animal model: a systematic review and meta-analysis.
topicTocotrienol Cholesterol Meta-Analysis
claimTocotrienol-rich fraction (TRF), a potent form of vitamin E, has demonstrated promising lipid-lowering effects due to its antioxidant and anti-inflammatory properties.
evidence level1
citationAbdah HW (2025)
sourceEffect of tocotrienol-rich fraction (TRF) on lipid profile in hyperlipidemic experimental animal model: a systematic review and meta-analysis.